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Poly-adenosine diphosphate ribose (PAR) is an important 
biopolymer which occurs as a post-translational modification of 
various proteins. PAR chains can be either linear or branched. In 
contrast to the linear PAR, the precise function of the branched 
PAR is still enigmatic. In 1981 Miwa et al. determined the 
structure of an enzymatically prepared branched PAR fragment to 
be O-α-D-ribofuranosyl-(1’’’→2’’)-O-α-D-ribofuranosyl-(1’’→2’)-
adenosine-5’,5’’,5’’’-tris(phosphate), in which the anomeric 
configurations of the glycosidic bonds agrees with linear PAR. 
However, after this first report no additional structural evidence 
has been published to support the initial assignment. In this 
paper, we present the first synthesis of the same branched PAR 
fragment. Subsequent NMR analysis strongly suggests that the 
chemical structure proposed by Miwa et al. is correct. 
Poly ADP ribosylation (PARylation) is an important post-
translational modification in which negatively charged ADP-
ribose units are transferred to an acceptor protein using NAD+ 
(nicotinamide adenine dinucleotide) as a donor and PARPs 
(poly ADP ribose polymerases) as the involved enzymes1, 2 
(Figure 1). PARylation and the resulting polymers (PARs) are 
involved in many biological events such as DNA repair, 
transcriptional regulation and apoptosis3. PAR chains can be 
either linear or branched4. Linear PAR can grow to over 200 
units in size, with a branching site occurring on average once 
every 20 to 50 elongation reactions1. While the knowledge on 
linear PAR is steadily growing, less progress is made with the 
role of branched PAR and its function is still unclear. There are 
a few reports on branched PAR after its discovery by Miwa et 
al4 at the end of 1970s. For example, the branched and not the 
linear PAR chains bind most preferably to histones5 and other 
nuclear proteins6. The branching point is reported not to be 
the endoglycosidic cleavage site of poly-ADP-ribose 
glycohydrolase (PARG)7 which indicates there might be 
undiscovered enzymes that specifically recognize the branched 
PAR structure8, 9. In 1981 the chemical structure of the 
branching point of PAR was established as O-α-D-
ribofuranosyl-(1’’’→2’’)-O-α-D-ribofuranosyl-(1’’→2’)-
adenosine-5’,5’’,5’’’-tris(phosphate) (Figure 1, 1) by Miwa et 
al2. They performed an enzymatic synthesis using NAD+ and 
calf thymus nuclei, to get PAR in vitro. Subsequent hydrolysis 
of all the pyrophosphate linkages in PAR by treatment with 
snake venom phosphodiesterase led to the isolation of 
branched PAR fragment 1. The configuration of 1 was 
determined by derivatization and with the aid of 
physicochemical techniques including gas chromatography, 
mass spectrometry, and 1H-NMR spectroscopy2. Shortly after 
the structure elucidation, two different groups10, 11 reported 
the existence of branched PAR in vivo, indicating that the 
branched PAR fragment made from enzymatic synthesis is 
indeed the naturally occurring product. Furthermore, 
enzymatic synthesis is widely applied to simulate in vivo 
conditions and to produce PAR12-14. In this respect, the organic 
synthesis of O-α-D-ribofuranosyl-(1’’’→2’’)-O-α-D-
ribofuranosyl-(1’’→2’)-adenosine-5’,5’’,5’’’-tris(phosphate) 1 is 
a challenging and valuable goal that can confirm this structure 
elucidation and will support future biological studies. As part 
of a program to develop synthetic methodologies towards PAR 
related molecules such as ribosylated amino acids15, mono-
ADP ribosylated peptides16, 17 and ADP ribose dimer and 
trimer18, we here present the synthesis and  structural analysis 
of compound 1. The synthetic route toward the O-α-D-
ribofuranosyl-(1’’’→2’’)-O-α-D-ribofuranosyl-(1’’→2’)-
adenosine-5’,5’’,5’’’-tris(phosphate) 1 is guided by our earlier 
reported synthesis of the core motif of branched PAR19 by 
adaptation of the protective group strategy and simultaneous 
introduction of three phosphate triester functions on the 
5’,5’’, 5’’’-primary hydroxyls of a suitably protected branched 
trisaccharide with phosphoramidite chemistry.  
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    The first stage of the synthetic route comprises the 
introduction of two challenging 1,2 cis-α-glycosidic linkages by 
the synthesis of key intermediate 620 (Scheme 1). We suggest 
to call the parent trisaccharide parotriose  (PAR + triose, Figure 
1, B) and the corresponding ribose disaccharide parobiose (A).  
The hydrogenolysis of the benzyl groups in fully protected 
parobiose, 2 (Scheme 1) obtained according to our earlier 
reported method18 was followed by removal of 
(triisopropylsilyl) TIPS group with HF·Pyridine to give 2’’,3’’,5’’-
OH parobiose derivative 3 in good yield. It is of interest that 
the presence of the TIPS instead of the benzyl group at the 5’-
OH of compound 2, avoided glycosidic bond cleavage during 
hydrogenolysis as reported in our previous study19, resulting in 
a significant improved yield and making a large scale synthesis 
possible. The 3’’,5’’-OH functions in triol 3 were selectively 
masked with the diol protecting TIPDS group by treatment 
with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (TIPDSCl2) in 
pyridine to get alcohol 4. Coupling of partially protected 
parobiose 4 with N-phenyl trifluoroacetimidate donor 5  
afforded the fully protected parotriose 6 with complete α-
selectivity and improved yield19. Subsequent introduction of 
adenine base requires a number of protective group 
manipulations. The benzyl-protecting groups in 6 should 
preferably be replaced because the adenine moiety would 
complicate hydrogenolysis20. However, we observed that the 
removal of benzyl ethers in 6 by Pd/C-catalyzed hydrogenation 
was tedious (more than 4 days) and was accompanied by ring 
opening or total cleavage of the TIPDS group. This side 
reaction could not be prevented by the use of other catalysts 
such as Pd(OH)2. We presumed that the lability of the TIPDS 
group on the trisaccharides made the hydrogenolysis 
problematic but selective removal of the TIPDS in 6 could not 
be attained. Therefore, we treated 6 with an excess of Et3N·HF 
for 24 h to remove all silyl groups. Hydrogenolysis of the thus 
obtained compound 7 using Pd/C in methanol for 24 h 
afforded compound 8, provided with five hydroxyl functions, in 
high yield (Scheme 2). Readjusting the protection by 
installation of TBDPS groups on the primary hydroxyls of 
compound 8 and acetylation of the remaining secondary 
hydroxyls set the stage for introduction of N6-benzolyadenine 
on the reducing end of parotriose 9. Vorbrüggen type 
glycosylation using HClO4-SiO2 as catalyst and persilylated N
6-
benzolyadenine proceeded completely β selective and 
furnished 10 in high yield19. The selective glycosylation on the 
N-9 position and not on the N-3 or N-7 positions was
ascertained by UV-spectroscopy. Before three identical
phosphate triesters could be installed on the 5’,5’’, 5’’’-primary
hydroxyls, protective group manipulation was required to
ensure regioselective phosphorylation. Thus, saponification of
the acetyl and benzoyl esters with aqueous NaOH in
pyridine/ethanol gave intermediate 11, allowing protection of
the remaining free 5’-OH group with a TBDPS group.
Surprisingly the reaction of the 5’-OH in 11 with TBDPSCl
failed, but fortunately the equally suitable TBS group was
introduced successfully using the more reactive TBSCl in
pyridine. Subsequent acetylation of this intermediate gave
fully protected 12. After removal of the silyl groups by
HF·pyridine all primary hydroxyl functions were released to
give triol 13, amenable to the simultaneous introduction of
three di-tert-butylphosphate triesters. Treatment of 13 with 10
equivalents di-tert-butyl-N,N–diisopropylphosphoramidite
using 1-methylimidazole and 1-methylimidazolium chloride as
activator combination under strictly anhydrous conditions21
and subsequent oxidation of the intermediate phosphite
Scheme 1. Synthesis of protected parotriose 6 from parobiose 2 
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triesters gave 14 in moderate yield. The low reactivity of 5’-OH 
of the adenosine moiety as noticed in the silylation of 11 
decreases also the yield of the phosphitylation reaction as the 
formation of target 14 was accompanied by bis-
phosphorylated product.  In the final stage, the tert-butyl 
groups of the phosphate triester in fully protected 14 were 
removed with HCl/HFIP in 1 h followed by ammonolysis of the 
acyl groups to furnish tris-phosphorylated parotriose 1 in 
excellent yield. 
    Having  target compound 1 at our disposal, we could 
compare the spectroscopic data of our synthetic product with 
those reported by Miwa2 for the natural product (Figure 2A). In 
the first instance, we observed significant differences between 
the 1H-NMR-spectra (see Supporting Information). We 
speculated that these differences originate mainly from a pH 
difference of the NMR samples, which in turn may be due to 
different isolation procedures. Our procedure involved global 
deprotection by ammonia treatment, followed by purification 
by HW-40 gel filtration using 0.15M NH4OAc in H2O as eluent 
under essentially neutral conditions. Contrary, Miwa firstly 
desalted the isolated product by DEAE-cellulose column 
chromatography, followed by column chromatography on 
phosphocellulose, which we could not easily attain. By doing 
this, Miwa obtained compound 1 as acidified sample (pH=3) 
while our product occurs in neutralized form (pH=7) as 
ammonium salt. To get a more accurate comparison, we 
changed the pH of our sample in D2O from 7 to 3 by adding 
CD3COOD. Under these conditions the NMR spectrum of our 
product and the one of Miwa proved to be virtually identical 
(Figure 2A vs Figure 2B). A small difference of multiplicity at 
R2’’’ and R3’’’ could be attributed to the slightly different field 
in our measurement. Overall the chemical shifts of all protons 
in our compound 1 are approximately 0.1 ppm upfield from 
those of Miwa’s compound mainly because of they used DSS 
(sodium 2,2-dimethyl-2-silapentane-5-sulfonate) as reference 
while we did not. Taken together, we conclude that the 
synthetic compound and the isolated compound have the 
same chemical structure. 
    In conclusion, for the first time, O-α-D-ribofuranosyl-
(1’’’→2’’)-O-α-D-ribofuranosyl-(1’’→2’)-adenosine-5’,5’’,5’’’-
tris(phosphate), a tris-phosphorylated branched PAR fragment 
was obtained by organic synthesis. Comparison of the  1H-NMR 
spectra of this fragment and the naturally occurring product 
showed the same chemical shifts which means that the 
structure of 1 was identical to the naturally occurring 
compound2 and that the regio- and stereochemistry of 
branching point of PAR was correctly elucidated by Miwa et al. 
Importantly, synthetic methodology in this work represents a 
next step to the future synthesis towards more complicated 
branched PAR fragments. Such fragments will be a valuable 
asset for future biological studies toward the biological 
function of branched ADPr. As last remark, we propose to give 
the disaccharide as occurs in linear PAR-chains parobiose and 
the native trisaccharide responsible for the branching points in 
PAR – parotriose, as trivial names.  
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